|
Research and Markets: Hyperphosphatemia In Chronic Kidney Disease …
Business Wire (press release) Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hyperphosphatemia In … |
Do Imaging Agents Cause Acute Kidney Injury? Mayo Study Questions the …HealthCanal.comMany physicians have long believed that the use of intravenous contrast agents for CT scans can cause acute kidney injury. New Mayo Clinic research questions the st…
Heart Failure Drug May Not Ease Symptoms in SomeWebMDThe medication, called spironolactone (Aldactone), failed to improve symptoms or quality of life among 422 patients with diastolic heart failure — a form of the disease that affects about half of al…
Mixed Results For Spironolactone In Heart Failure With Preserved Ejection …ForbesAlthough the mineralocorticoid receptor antagonists (MRAs) spironolactone and eplerenone (Inspra, Pfizer) have been shown to be beneficial in patients with heart failure…
Spironolactone disappoints in preserved-EF heart failure: Aldo-DHF in printTheHeart.OrgChicago, IL – A year of aldosterone blockade failed to improve exercise capacity, symptoms, or quality-of-life measures in a placebo-controlled trial of >400 pati…
|
CU prof given grant to study heart failure
Boulder County Business Report BOULDER – University of Colorado-Boulder professor Leslie Leinwand received a $45,837 grant to study a protein that causes heart failure in adults and children. Leinwand plans to use the grant from the Children’s Cardiomyopathy Foundation to study the … |
|
Research and Markets: Hyperphosphatemia In Chronic Kidney Disease …
PharmiWeb.com (press release) Research and Markets (http://www.researchandmarkets.com/research/479g7c/hyperphosphatemia) has announced the addition of Global Markets Direct’s new report “Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012″ to their … |
|
Healthcare Colloquium First to Implement New ST2 Blood Test in Heart Failure …
eReleases (press release) 26, 2013 /PRNewswire/ – The Healthcare Accreditation Colloquium announced today the first use of ST2, a new blood test for heart failure, as part of an accreditation process for hospitals. “Our work began in 2011,” said Dr. Tony Joseph, Colloquium CEO. |
|
Research and Markets: Hyperphosphatemia In Chronic Kidney Disease …
Fort Mills Times Research and Markets (http://www.researchandmarkets.com/research/479g7c/hyperphosphatemia) has announced the addition of Global Markets Direct’s new report “Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012″ to their … |
USF doctor leads team to discover DNA-heart failure linkNorthwest News and TribuneIn a development that could potentially benefit millions suffering from heart failure, a research team headed by a University of South Florida doctor has identified a gen…